The effect of membrane stabilizing agents on induction of the immune response. I. Effect of lymphocyte activation in mixed lymphocyte reactions by unknown
Brief Definitive Report 
THE  EFFECT  OF  MEMBRANE  STABILIZING AGENTS  ON 
INDUCTION  OF THE  IMMUNE  RESPONSE 
I. Effect of Lymphocyte Activation in Mixed 
Lymphocyte Reactions* 
BY J.  DOUGLAS  WATERFIELD,  LENNART  HAMMARSTROM,  AND EDVARD  SMITH 
(From the Division of  Immunobiology, Karolinska Institute, Wallenberglaboratoriet, Lilla Frescati, 
104 05 Stockholm 50 Sweden) 
In vitro studies of the mixed lymphocyte reaction (MLR) and subsequent cell- 
mediated lympholysis (CML)  (1,  2)  have  been  useful  in  identification and 
investigation of the cell populations involved in the allograft response (3-5).  As 
both the inductive and effector phases of the in vitro response require recogni- 
tion  of the  histoincompatible cells  through membrane-associated receptors, 
workers have further approached the delineation of the these populations on a 
pharmacological basis, through the use of chlorpromazine, a membrane-stabiliz- 
ing drug, to inhibit induction and/or effector function (6). Results have shown 
that chlorpromazine inhibits both MLR and MLR generation of cytotoxic lym- 
phocytes, the latter by blocking a postproliferative membrane-mediated event 
required in the generation of cytotoxic effector lymphocytes. In contrast, the 
drug was shown to have no effect on the recognition, binding, or lysis of target 
cells by already sensitized lymphocytes. It was postulated that the drug affected 
the T-cell population capable of cell division upon recognition of LD or Lad cell 
surface structures and by some surface-associated mechanism prevented subse- 
quent development of cytotoxic effector cells  capable of recognizing the  SD 
surface components. The present report deals with experiments designed to test 
other membrane-stabilizing drugs,  imipramine and lidocain,  to see whether 
they exert similar effects to those described for chlorpromazine. 
Materials and Methods 
Drugs.  Chlorpromazine,  imipramine,  and  lidocain  were  purchased  from  Leo  (Helsinborg, 
Sweden),  Ciba-Geigy  (Basel,  Switzerland),  and  Astra  (Sodertalje,  Sweden),  respectively,  and 
were maintained in balanced salt solution (BSS) at 0°C in stock solutions before use in the MLR 
assay. 
Cell Preparations.  Spleen cell suspensions from either C57BL or CBA mice were obtained by 
pressing the spleens through stainless steel grids under sterile conditions. The resultant suspen- 
sions were pipetted vigorously and cellular aggregates allowed to settle for 5 min. The cells were 
then washed twice with BSS and resuspended to a  final concentration of 107/ml in RPMI media 
containing 5% heat-inactivated fetal calf serum, 100 IU penicillin/ml and 100 ~g streptomycin/ml, 
and 5  ×  10  -'~ M  2-mercaptoethanol. Cells designated as stimulators in the MLR were irradiated 
with 1,400 R using an Elma X-ray source emmiting 50 R/rain. 
Mixed Lymphocyte Reaction.  Spleen cell suspensions from C57BL mice (107/ml) were set up in 
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Falcon Microtest Ii tissue  culture plates (Falcon Plastics,  Oxnard, Calif.)  in a 0.05-ml vol.  The 
stimulator cells  (107/ml  CBA-irradiated spleen cells)  were added to the responder cells  also  in a 
0.05-mi vol.  All groups received 0.02  rnl complete RPMI media. The drugs were added to the 
cultures in a 0.02-mi vol at various time intervals after the initiation  of the MLR.  Controls 
consisted  of  similar mixtures differing  only by the inclusion  of  C57BL splenic  lymphocytes as  the 
stimulator cells.  The cultures  were  placed in  plastic  boxes,  gassed  with  a 10% CO2, 7% 02,  and  83% 
N2 mixture, and incubated at  37°C  for  72  h. [aH]thymidine (0.02  ml,  25  izCi/ml)  was then  added  and 
the  cultures  incubated  for  a further  24  h,  at  which time  they  were harvested on  a Skatron multiple 
cell-culture  harvester  (Skatron A-S 3401 Lierbyen, Norway). The samples were counted on a 
Packard Tri-Carb liquid  scintillation  spectrometer (Packard Instrument Co.,  Inc.,  Warrensville, 
Ind.). MLR  and control groups were assessed for the total  counts per minute (cpm)-thymidine 
uptake as  well as viable cells/culture. 
Results and Discussion 
Effect of Membrane-Stabilizing Agents on the Proliferative Response  in the 
MLR.  To compare the effects of imipramine and lidecain to those caused by 
chloropromazine, one-way MLRs were set up as described in the Materials and 
Methods section.  The concentrations of drugs added to both the control and 
stimulated cultures were determined previously and represented the doses that 
caused suppression of mitogenic activation of cells (L. HammarstrSm, manu- 
script in preparation). The drugs were added at 0, 24, 48, and 72 h after initiation 
of the response. 
Fig.  1 shows the effects of chlorpromazine on  proliferation in  MLR  after 
various time periods in culture. Chlorpromazine at 1.6 ~g/ml (5 × 10  -~ M) only 
inhibited the MLR significantly when present in the cultures for 96  h.  The 
inhibition in these groups did not correlate with decreased numbers of viable 
cells. However, the inhibition of the MLR after inclusion of the drug at 16 ~g/ml 
appeared to be  caused by toxic properties of the compound. Thus,  MLR re- 
sponses, control background cpm, and presence of viable cells in the cultures 
were abolished if the drug was present longer than 24 h, marginal responses and 
viable cell numbers being seen before this time. The findings could be explained 
in one of two ways. There could be a time requirement for expression of toxicity 
on the responding cells in culture. This period would be about 24 h, as a 50% 
decrease in viable cell number is seen at this time. Otherwise, it is possible that 
cells in advanced stages of activation (72 h) are less susceptible to the toxic 
effects of the drug. At present we are not able to distinguish between these two 
possibilities. Fig. 2 and Fig. 3 show comparative studies using the membrane- 
stabilizing  drugs imipramine and lidocain.  It  can be  seen from Fig.  2  that 
imipramine at 10 ~g/ml (3.2 x 10  -~ M) inhibits the MLR if  present in the culture 
for at least 48 h. In these groups the inhibition seen could be explained by a 
decrease in the number of viable cells. Imipramine at concentrations of 100 ~g/ 
ml was totally toxic if present in culture for longer than 24 h. Similarly, in Fig. 
3, concentrations of lidocain of 1.0 mg/ml (4.3 × 10  -3 M) and 10 mg/ml inhibited 
the MLR, the inhibition seen at the latter concentration again correlating with 
total absence of viable cells. 
The inhibition of the MLR affected by low concentrations of the three drugs 
was paralleled in two instances by a decrease in the number of viable cells per 
culture. This decrease could be explained in several ways: either the drugs are 
directly toxic to the responding cells in culture or the drugs function as was 3.0 
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FIG.  1.  The effect of chlorpromazine on activation of C57BL splenic lymphocytes in the 
one-way MLR, C57BL spleen cells were activated in culture by either X-irradiated C57BL or 
CBA stimulator cells. The drug was added to the MLR 0, 24, 48, or 72 h after initiation of the 
cultures.  The reaction was tritiated after 72 h  and harvested 24 h  later.  At this time all 
groups were assessed for total thymidine uptake as well as the number of viable cells. The 
results represent the mean cpm and standard  error  from both control cultures  (C57BL 
stimulator cells) ([]) and activated cultures (CBA stimulator cells) (D) with either (A) no 
chlorpromazine,  (B) chlorpromazine at 1.6/~g/ml, or (C) chlorpromazine at 16/~g/ml, the 
drug being added at the time indicated. The corresponding viable cell number/milliliter in 
the activated cultures are also shown (11--11). 
3.0  3.0 
2,4 
~,~  1.8 
o 
x 
:E 
a.  1,2  u 
0.6 
w 
A  B  C  A  B  C 
0  24 
I 
i 
j 
I  II 
.I 
A  8  C  A  B  C 
-  48  72 
2.4 
o 
x 
1.8 
m 
Z 
1,2  ~ 
v 
w 
0.6  > 
ADDITION  OF  I)RUG  (h  AFTER  INITIATION  OF  CULTURE) 
FIG.  2.  The effect of imipramine on activation of C57BL splenic lymphocytes in the one- 
way MLR. The experimental design was set up as described for Fig. 1. The results represent 
the mean cpm and standard error from both control cultures (C57BL stimulator cells) (~1) 
and  activated  cultures  (CBA  stimulator cells)  (n)  with  either  (A)  no  imipramine,  (B) 
imipramine at 10/~g/ml, or (C) imipramine at 100/~g/ml, the drug being added at the times 
indicated. The corresponding viable cell number/ml in the activated cultures are also shown 
(11--11). 
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FzG.  3.  The effect of lidocain on activation of C57BL splenic lymphocytes in the one-way 
MLR. The experimental design was set up as described for Fig. 1. The results represent the 
mean cpm and standard error from both control cultures (C57BL stimulator cells) ([]) and 
activated cultures (CBA stimulator cells) (n) with either (A) no lidocain,  (B) lidocain at 1 
mg/ml,  or  (C)  lidocain  at  10  mg/ml,  the  drug  being  added  at  the  times  indicated.  The 
corresponding viable cell number/ml  in the activated cultures are also shown  (Ig--gg). 
previously postulated by blocking cellular activation, thus affecting DNA syn- 
thesis and cell division. We feel that the first possibility is only tenable as the 
decrease  in  cell  number  with  10  /~g/ml  imipramine  and  1  mg/ml  lidocain 
occurred  also  in control  cultures  (C57BL  vs.  C57BL  irradiated,  data  not in- 
cluded). However, to further test this possibility the MLR was set up including 
doubling dilutions of the three drugs at the initiation of the cultures.  It was 
reasoned that if cellular activation was blocked due to a direct toxic effect, a 
linear decrease in the number of viable cells would be seen with increasingly 
higher concentrations of the drugs. Conversely, if the drugs blocked activation 
by a nontoxic mechanism, as has been shown for hydroxyurea, DNA synthesis 
would be inhibited and viable cell number would remain constant at various 
concentrations higher than that used for the maximal suppression.  As can be 
seen from Fig. 4, the decrease in cellular activation during the MLR correlated 
completely with the loss of viable cells from the cultures. 
The  doses  of the  various  membrane-stabilizing  drugs  required  to  attain 
suppression in the MLR differed considerably. However, in each case, suppres- 
sion was concomitant with the loss of cells capable of synthesizing DNA at the 
end of the culture period and can only be explained as being due to the toxicity of 
the  compounds.  The  differences  between  these  findings  and  those  reported 
previously,  indicating that suppression of the MLR is not caused by a  direct 
toxic action of the drugs, can not be explained at the present time. 
We feel that these studies serve to indicate the pitfalls involved in interpreta- 
tion of data derived from experiments of this type. It is imperative when using 
such  drugs  for studying  a  defined  lymphocyte  function  to  control  that  the 566  WATERFIELD  ET  AL.  BRIEF  DEFINITIVE  REPORT 
3.5 
2.8 
2.1 
o 
x 
1.4 
0.7 
I 
0  2  4  8  16 
C HLORPROMAZ  I NE 
(p.g/ml) 
0  0 
4-- 
:1 
5  I0  20  40  80  160 
IMIPRAMINE 
(~g/ml) 
.5  I  2  4  8  16 
LIDOCAIN 
(mg/ml) 
2.8 
o 
x 
Z 
].4  LI 
<{ 
> 
0.7 
FIG.  4.  The effect of chlorpromazine,  imipramine,  and  lidocain  on  activation  of C57BL 
splenic lymphocytes in the one-way MLR.  C57BL spleen cells were activated in culture by 
X-irradiated CBA stimulater cells. The drugs were added to the MLR at the initiation of the 
cultures.  The results represent the mean cpm and standard error from activated cultures, 
the drugs  being  added  to the  MLR  in  the  concentrations  indicated.  The  mean  cpm  and 
standard  error  from  control  cultures  without  the  drugs  included  was  9,898  ±  736.  The 
corresponding viable cell number/ml  in the activated cultures are also shown  (l--E). 
biological  effects  measured  can  be  explained  only  by  a  direct  effect  on  the 
function investigated and not to more indirect effects induced by the drug. 
Summary 
The  effect  of three  membrane-stabilizing  agents,  chlorpromazine,  imipra- 
mine, and lidocain, on in vitro activation of cellular responses was studied using 
the one-way MLR. Cellular activation was found to be depressed by these drugs. 
However, the degree of suppression paralleled the decline of viable cells in the 
cultures. It is concluded that drug-induced inhibition of MLR was due solely to 
the toxicity of the compounds. 
Received for publication 7 May 1976. 
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